WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

Innovative Drugs: The New Battleground in US-C... (12/11/2025)

Chinese Biopharma Sector Posts 22 Financings ... (12/11/2025)

China Tightens Oversight as Domestic Innovator... (12/11/2025)

Global Pharmas Turn to China Not Just for Asse... (12/9/2025)

China Launches National Drug Price Registratio... (12/2/2025)

NHC Releases 2024 China Health Statistics Bull... (12/2/2025)

China Used to Be a Cash Cow for Western Compan... (12/2/2025)

MNC's County-Level Ambitions Falter as Strateg... (12/1/2025)

LEK: China's Clinical Trial Sector Enters a Ne... (11/28/2025)

MC's China Biopharma Tracker: Dealmaking, Appr... (11/27/2025)

China's Biopharma Innovation Surges — McKinse... (11/21/2025)

US Report Flags Risks From China's Expanding C... (11/21/2025)

Recent Executive Moves (12/12/2025) Sidera Secures $109M in Major Series A a... (12/12/2025) Abraham Accords Partners Could Help the ... (12/12/2025) CMS's NDA for Innovative Stroke Drug Y-... (12/12/2025) Ascletis' Acne Drug Denifanstat Enters N... (12/12/2025) InnoCare Pharma Wins NMPA Approval for N... (12/12/2025) 73 Mainland Chinese Biotech/MedTech Firm... (12/11/2025) China Approves Sanofi's Qfitlia (fitusir... (12/11/2025) Forward Pharma Reports Promising Early D... (12/11/2025) Hengrui Launches Phase 1/2 Trial of Subc... (12/11/2025) Kelingyuan Reports Early Tumor Responses... (12/11/2025) Zealand and OTR Thera Form $2.5B Allia... (12/11/2025) China Approves Boehringer Ingelheim's Ja... (12/11/2025) Syneron Secures ~$100M to Advance Macroc... (12/11/2025) China Pushes Private Insurance to Cover ... (12/11/2025) Formation Bio Secures Global Rights to L... (12/11/2025) China's Human Vaccine Market Set for Ste... (12/10/2025) Dizal Showcases Broad ASH25 Data for Gol... (12/10/2025)

China's Human Vaccine Market Set for Steady Long-Term E... China's Pharmaceutical Market Enters a New Consumer-Dri... China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i...

Sidera Secures $109M in Major Series A and Global Right... Formation Bio Secures Global Rights to Lynk Pharma's CN... Syneron Secures ~$100M to Advance Macrocyclic Peptide D... Zealand and OTR Thera Form $2.5B Alliance to Develop ... 73 Mainland Chinese Biotech/MedTech Firms Flock to Hon...

China Releases 99th Batch of Reference Formulations Cat... China Issues Revised Guideline on Grading Adverse Event... CDE Seeks Comments on Draft Guidelines Defining Major D... CDE Solicits Comments on Draft Guidance for Computerize... NMPA Issues New Rules on Inspections and Export Certifi...

China Pushes Private Insurance to Cover High-Cost Innov... China Releases Updated NRDL and First Commercial Insura... China's Healthcare Costs Shift to Individuals as Govern... China Expands Grassroots Healthcare Access with More Do... China Pilots Next-Generation AI Reforms Across Public H...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S... Sanofi Launches €1B Insulin API Manufacturing Project ...

InnoCare Pharma Wins NMPA Approval for Next-Gen TRK Inh... Ascletis' Acne Drug Denifanstat Enters NMPA Review Afte... CMS's NDA for Innovative Stroke Drug Y-3 for Injection... China Approves Boehringer Ingelheim's Jascayd for Progr... Kelingyuan Reports Early Tumor Responses for Novel HER2...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Former CFDA Boss Bi Jingquan Expelled From Party, Faces... Recent Executive Moves Recent Executive Moves Former NMPA Deputy Head Prosecuted for Bribery

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...